Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE44.0000
- TODAY'S CHANGE (%)1.8800 (4.4634%)
- Bid / Lots42.0000/ 1
- Ask / Lots47.7500/ 1
- Open / Previous Close42.4700 / 42.1200
- Day Range
- 52 Week Range
- Volume676,136
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2500 | 42.14 |
| 09:34 ET | 800 | 42.8 |
| 09:36 ET | 2240 | 42.895 |
| 09:38 ET | 2200 | 42.49 |
| 09:39 ET | 3719 | 41.95 |
| 09:41 ET | 3300 | 42.13 |
| 09:43 ET | 3255 | 41.765 |
| 09:45 ET | 4236 | 41.73 |
| 09:48 ET | 5210 | 41.89 |
| 09:50 ET | 200 | 41.9 |
| 09:52 ET | 2927 | 42 |
| 09:54 ET | 500 | 41.99 |
| 09:56 ET | 300 | 41.985 |
| 09:57 ET | 1004 | 41.9601 |
| 09:59 ET | 6900 | 42.05 |
| 10:01 ET | 900 | 42.05 |
| 10:03 ET | 1900 | 42.02 |
| 10:06 ET | 700 | 42.01 |
| 10:08 ET | 6446 | 42.16 |
| 10:10 ET | 600 | 42.185 |
| 10:12 ET | 1800 | 42.08 |
| 10:14 ET | 917 | 42.13 |
| 10:15 ET | 472 | 42.08 |
| 10:17 ET | 1751 | 42.31 |
| 10:19 ET | 1201 | 42.66 |
| 10:21 ET | 1408 | 42.52 |
| 10:24 ET | 600 | 42.54 |
| 10:26 ET | 200 | 42.61 |
| 10:28 ET | 100 | 42.64 |
| 10:32 ET | 100 | 42.79 |
| 10:33 ET | 2217 | 42.8474 |
| 10:35 ET | 4449 | 43.02 |
| 10:37 ET | 200 | 43.04 |
| 10:39 ET | 1845 | 42.835 |
| 10:42 ET | 400 | 42.8195 |
| 10:44 ET | 200 | 42.755 |
| 10:46 ET | 200 | 42.745 |
| 10:51 ET | 200 | 42.76 |
| 10:55 ET | 1450 | 42.76 |
| 10:57 ET | 3010 | 42.75 |
| 11:00 ET | 200 | 42.74 |
| 11:02 ET | 205 | 42.7 |
| 11:04 ET | 300 | 42.77 |
| 11:06 ET | 1000 | 42.63 |
| 11:08 ET | 700 | 42.6472 |
| 11:09 ET | 300 | 42.69 |
| 11:13 ET | 500 | 42.775 |
| 11:15 ET | 500 | 42.76 |
| 11:18 ET | 300 | 42.81 |
| 11:20 ET | 100 | 42.805 |
| 11:22 ET | 2145 | 42.775 |
| 11:24 ET | 1600 | 42.91 |
| 11:27 ET | 299 | 42.85 |
| 11:29 ET | 1042 | 42.77 |
| 11:31 ET | 500 | 42.82 |
| 11:33 ET | 500 | 42.8 |
| 11:36 ET | 700 | 42.925 |
| 11:38 ET | 900 | 42.905 |
| 11:42 ET | 5088 | 42.99 |
| 11:44 ET | 1600 | 43.0525 |
| 11:45 ET | 2700 | 43.26 |
| 11:47 ET | 8848 | 43.38 |
| 11:49 ET | 1400 | 43.46 |
| 11:51 ET | 18426 | 43.77 |
| 11:54 ET | 7510 | 43.91 |
| 11:56 ET | 4053 | 43.73 |
| 11:58 ET | 3806 | 43.92 |
| 12:00 ET | 8405 | 44.41 |
| 12:02 ET | 9292 | 44.67 |
| 12:03 ET | 6854 | 44.61 |
| 12:05 ET | 800 | 44.62 |
| 12:07 ET | 500 | 44.605 |
| 12:09 ET | 6583 | 44.7 |
| 12:12 ET | 32385 | 44.825 |
| 12:14 ET | 2500 | 44.76 |
| 12:16 ET | 1024 | 44.82 |
| 12:18 ET | 3494 | 44.805 |
| 12:20 ET | 5124 | 44.53 |
| 12:21 ET | 299 | 44.65 |
| 12:27 ET | 100 | 44.68 |
| 12:30 ET | 115 | 44.51 |
| 12:32 ET | 400 | 44.78 |
| 12:34 ET | 581 | 44.741 |
| 12:36 ET | 500 | 44.75 |
| 12:38 ET | 567 | 44.7 |
| 12:39 ET | 900 | 44.77 |
| 12:41 ET | 400 | 44.68 |
| 12:43 ET | 894 | 44.82 |
| 12:45 ET | 945 | 44.78 |
| 12:48 ET | 400 | 44.84 |
| 12:50 ET | 407 | 44.75 |
| 12:52 ET | 300 | 44.88 |
| 12:54 ET | 1305 | 44.835 |
| 12:56 ET | 400 | 44.83 |
| 12:57 ET | 210 | 44.7301 |
| 12:59 ET | 551 | 44.85 |
| 01:03 ET | 2080 | 44.87 |
| 01:06 ET | 100 | 44.87 |
| 01:08 ET | 300 | 44.85 |
| 01:12 ET | 200 | 44.85 |
| 01:14 ET | 341 | 44.84 |
| 01:15 ET | 2389 | 44.72 |
| 01:17 ET | 1463 | 44.72 |
| 01:19 ET | 10116 | 44.82 |
| 01:21 ET | 8236 | 44.59 |
| 01:24 ET | 4160 | 44.53 |
| 01:26 ET | 200 | 44.43 |
| 01:28 ET | 100 | 44.5 |
| 01:33 ET | 2798 | 44.4 |
| 01:35 ET | 558 | 44.47 |
| 01:37 ET | 2500 | 44.51 |
| 01:39 ET | 1000 | 44.5 |
| 01:42 ET | 100 | 44.52 |
| 01:46 ET | 2400 | 44.43 |
| 01:50 ET | 100 | 44.3825 |
| 01:53 ET | 1300 | 44.21 |
| 01:55 ET | 200 | 44.215 |
| 01:57 ET | 850 | 44.33 |
| 02:00 ET | 600 | 44.37 |
| 02:02 ET | 1400 | 44.47 |
| 02:04 ET | 100 | 44.5 |
| 02:06 ET | 1500 | 44.37 |
| 02:08 ET | 900 | 44.41 |
| 02:11 ET | 400 | 44.5 |
| 02:15 ET | 300 | 44.38 |
| 02:18 ET | 3857 | 44.41 |
| 02:20 ET | 600 | 44.4 |
| 02:24 ET | 100 | 44.47 |
| 02:26 ET | 200 | 44.45 |
| 02:27 ET | 2200 | 44.58 |
| 02:31 ET | 4400 | 44.575 |
| 02:33 ET | 700 | 44.5 |
| 02:36 ET | 300 | 44.4 |
| 02:38 ET | 777 | 44.31 |
| 02:40 ET | 400 | 44.27 |
| 02:42 ET | 715 | 44.435 |
| 02:44 ET | 400 | 44.39 |
| 02:45 ET | 100 | 44.43 |
| 02:47 ET | 1000 | 44.47 |
| 02:51 ET | 536 | 44.37 |
| 02:54 ET | 200 | 44.405 |
| 02:56 ET | 2400 | 44.44 |
| 02:58 ET | 800 | 44.45 |
| 03:00 ET | 300 | 44.49 |
| 03:02 ET | 2200 | 44.22 |
| 03:03 ET | 3350 | 44.085 |
| 03:07 ET | 6613 | 43.83 |
| 03:09 ET | 941 | 43.99 |
| 03:12 ET | 200 | 44.04 |
| 03:14 ET | 200 | 44.07 |
| 03:16 ET | 700 | 43.92 |
| 03:18 ET | 1500 | 43.88 |
| 03:20 ET | 500 | 43.89 |
| 03:21 ET | 1100 | 43.92 |
| 03:23 ET | 1950 | 43.89 |
| 03:25 ET | 891 | 43.92 |
| 03:27 ET | 100 | 43.99 |
| 03:30 ET | 1359 | 43.99 |
| 03:32 ET | 700 | 44.045 |
| 03:34 ET | 2356 | 44.1859 |
| 03:36 ET | 1560 | 44.13 |
| 03:38 ET | 300 | 44.145 |
| 03:39 ET | 400 | 44.13 |
| 03:41 ET | 4192 | 43.96 |
| 03:43 ET | 922 | 43.975 |
| 03:45 ET | 4641 | 44 |
| 03:48 ET | 400 | 44.03 |
| 03:50 ET | 1934 | 44.05 |
| 03:52 ET | 5210 | 43.98 |
| 03:54 ET | 3029 | 44 |
| 03:56 ET | 5754 | 44.085 |
| 03:57 ET | 10486 | 43.96 |
| 03:59 ET | 18486 | 44 |
Apr 11, 2024
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Thursday Apr 11, 2024 by Dow Jones
4:05PM ET on Thursday Apr 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.3B | -11.9x | --- |
Iovance Biotherapeutics Inc | 3.3B | -6.4x | --- |
SpringWorks Therapeutics Inc | 3.4B | -9.0x | --- |
Biohaven Ltd | 3.4B | -7.0x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -15.7x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
|---|---|
Revenue (TTM) | $4.0M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-3.70 |
Book Value | $7.91 |
P/E Ratio | -11.9x |
Price/Sales (TTM) | 817.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,547.17% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
